- Home
- BRAG vs CRDL Comparison
BRAG vs CRDL Comparison
Compare BRAG & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRAG
- CRDL
- Stock Information
- Founded
- BRAG 2018
- CRDL 2017
- Country
- BRAG Canada
- CRDL Canada
- Employees
- BRAG N/A
- CRDL N/A
- Industry
- BRAG Office Equipment/Supplies/Services
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BRAG Technology
- CRDL Health Care
- Exchange
- BRAG Nasdaq
- CRDL Nasdaq
- Market Cap
- BRAG 117.8M
- CRDL 105.8M
- IPO Year
- BRAG N/A
- CRDL N/A
- Fundamental
- Price
- BRAG $4.35
- CRDL $1.31
- Analyst Decision
- BRAG Strong Buy
- CRDL Strong Buy
- Analyst Count
- BRAG 3
- CRDL 3
- Target Price
- BRAG $7.33
- CRDL $9.33
- AVG Volume (30 Days)
- BRAG 47.9K
- CRDL 233.6K
- Earning Date
- BRAG 08-07-2025
- CRDL 08-11-2025
- Dividend Yield
- BRAG N/A
- CRDL N/A
- EPS Growth
- BRAG N/A
- CRDL N/A
- EPS
- BRAG N/A
- CRDL N/A
- Revenue
- BRAG $112,078,469.00
- CRDL N/A
- Revenue This Year
- BRAG $17.94
- CRDL N/A
- Revenue Next Year
- BRAG $9.56
- CRDL N/A
- P/E Ratio
- BRAG N/A
- CRDL N/A
- Revenue Growth
- BRAG 9.76
- CRDL N/A
- 52 Week Low
- BRAG $2.86
- CRDL $0.77
- 52 Week High
- BRAG $6.12
- CRDL $2.63
- Technical
- Relative Strength Index (RSI)
- BRAG 50.40
- CRDL 48.17
- Support Level
- BRAG $4.16
- CRDL $1.22
- Resistance Level
- BRAG $4.33
- CRDL $1.50
- Average True Range (ATR)
- BRAG 0.12
- CRDL 0.09
- MACD
- BRAG 0.01
- CRDL -0.01
- Stochastic Oscillator
- BRAG 58.57
- CRDL 28.57
About BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, United States, Croatia, and other regions.
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.